The molecule developed by UB researchers acts like a long-lasting anesthetic, with a single, local injection providing pain ...

Myrio's PHOX2B PC-CAR T therapy gains FDA approval for human trials, promising innovative treatment for patients with ...

The U.S. Food and Drug Administration (FDA) has approved Myrio Therapeutics' Investigational New Drug (IND) application for its lead product, PHOX2B PC-CAR T, paving the way for human trials in ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Topline results from the chronic cohort of an ongoing phase 1b/2a clinical trial of an investigational therapeutic peptide, NVG-291, found the novel treatment led to increased electrical connectivity ...

A new molecule developed by University at Buffalo researchers acts like a local, long-lasting anesthetic, providing robust ...

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...

Health and Human Services Secretary Robert F. Kennedy, Jr. doubled down on his support for non-pharmaceutical health ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.